Inactive Instrument

Calendar Novavax, Inc. Nasdaq

Equities

US6700021040

Chart calendar Novavax, Inc.

e8.IdXC8ISqiJxbuMCv4TpCrdq1op_YJgnkv9ynhhOB4J0.U52om7HO6e8B3o7iuElz2IrcxtC6Ynqr5amK73nXq_lxpIHD7ti47Ajarw~661504061944793f6b1f7563a141eb88

Upcoming events on Novavax, Inc.

2024-05-06 Q1 2024 Earnings Release (Projected)
2024-08-05 Q2 2024 Earnings Release (Projected)
2024-11-05 Q3 2024 Earnings Release (Projected)
2025-03-03 Q4 2024 Earnings Release (Projected)

Past events on Novavax, Inc.

2024-03-06 01:30 pm TD Cowen Health Care Conference
2024-02-28 08:30 am Q4 2023 Earnings Call
2024-02-28 08:00 am Q4 2023 Earnings Release
2024-01-08 08:15 pm JPMorgan Healthcare Conference
2023-11-15 04:00 am Jefferies London Healthcare Conference
2023-11-09 08:32 am Q3 2023 Earnings Release
2023-11-09 08:30 am Q3 2023 Earnings Call
2023-10-19 04:30 am World Vaccine Congress - Perretti, A
2023-10-18 08:00 am World Vaccine Congress - Shinde, V
2023-10-17 07:45 am World Vaccine Congress - Zatonski, M
2023-10-14 12:15 pm IDWeek Conference - Poster No. - 2337
2023-10-13 12:15 pm IDWeek Conference - Poster No. - 1371
2023-09-12 10:15 am Baird Global Healthcare Conference
2023-09-11 04:30 pm H.C. Wainwright Global Investment Conference
2023-08-08 08:30 am Q2 2023 Earnings Call
2023-08-08 08:00 am Q2 2023 Earnings Release
2023-07-11 08:30 am Annual General Meeting
2023-06-08 09:00 am Jefferies Global Healthcare Conference
2023-05-11 01:00 pm Bank of America Healthcare Conference
2023-05-09 08:30 am Q1 2023 Earnings Call

Annual results

Fiscal PeriodDecember 2019 2020 2021 2022 2023 2024
Net sales
Million USD
Released
Forecast
Spread
18,7
11,8
57.99%
476
398
19.36%
1 146
1 263
-9.25%
1 982
1 947
1.77%
984
1 014
-3.03%

850

EBITDA
Million USD
Released
Forecast
Spread
0,00
0,00
-
0,00
0,00
-
0,00
0,00
-
-616
-455
-35.42%
-525
-487
-7.88%

-111

EBIT
Million USD
Released
Forecast
Spread
-130
-121
-7.5%
-417
-393
-6.04%
-1 687
-979
-72.21%
-645
-480
-34.41%
-567
-424
-33.66%

-62,4

Earnings before Tax (EBT)
Million USD
Released
Forecast
Spread
-133
-128
-3.94%
-418
-383
-9.33%
-1 715
-1 007
-70.2%
-654
-548
-19.24%
-543
-394
-37.66%

-101

Net income
Million USD
Released
Forecast
Spread
-133
-130
-2.38%
-418
-383
-9.33%
-1 744
-1 021
-70.82%
-658
-548
-20.13%
-545
-413
-31.9%

-90,5

EPS
USD
Released
Forecast
Spread
-5,51
-5,42
-1.59%
-7,27
-6,58
-10.53%
-23,4
-13,7
-71.07%
-8,42
-6,98
-20.66%
-5,41
-4,22
-28.15%

-0,80

Announcement Date11/03/2001/03/2128/02/2228/02/2328/02/24-

Quarterly results

Fiscal PeriodDecember 2021 Q4 2022 Q1 2022 Q2 2022 Q3 2022 Q4 2023 Q1 2023 Q2 2023 Q3 2023 Q4 2024 Q1 2024 Q2 2024 Q3 2024 Q4
Net sales
Million USD
Released
Forecast
Spread
222
332
-33.03%
704
845
-16.71%
186
1 017
-81.72%
735
555
32.24%
357
383
-6.72%
81,0
94,5
-14.35%
424
259
63.88%
187
96,5
93.76%
291
322
-9.51%

101


76,7


77,4


617

EBITDA
Million USD
Released
Forecast
Spread









-119
310
-138.36%












-173
-120
-43.73%

-149


-121


-109


186

EBIT
Million USD
Released
Forecast
Spread
-825
-114
-626.51%
209
247
-15.35%
-483
486
-199.33%
-127
139
-191.53%
-244
-90,2
-170.23%
-313
-278
-12.54%
55,5
-121
145.98%
-126
-223
43.74%
-184
-40,9
-348.58%

-134


-96,3


-108


272

Earnings before Tax (EBT)
Million USD
Released
Forecast
Spread
-830
-118
-604.95%
206
242
-14.95%
-509
495
-202.89%
-166
93,2
-278.36%
-185
-87,8
-110.23%
-293
-299
2.07%
57,9
-94,1
161.53%
-131
-214
38.43%
-177
-26,9
-555.91%

-139


-104


-109


250

Net income
Million USD
Released
Forecast
Spread
-846
-124
-584.19%
203
213
-4.69%
-510
449
-213.66%
-169
132
-227.32%
-182
-74,2
-145.57%
-294
-291
-1.16%
58,0
-101
157.16%
-131
-217
39.77%
-178
-46,5
-283.41%

-136


-102


-107


244

EPS
USD
Released
Forecast
Spread
-11,2
-1,80
-520.36%
2,56
2,65
-3.54%
-6,53
5,50
-218.68%
-2,15
1,64
-231.02%
-2,28
-1,01
-126.76%
-3,41
-3,42
0.29%
0,58
-1,16
149.81%
-1,26
-2,29
45.05%
-1,44
-0,45
-221.19%

-1,10


-0,81


-0,80


1,71

Announcement Date28/02/2209/05/2208/08/2208/11/2228/02/2309/05/2308/08/2309/11/2328/02/24----